NASDAQ:IBB - Nasdaq - US4642875565 - ETF - Currency: USD
ISHARES BIOTECHNOLOGY ETF
NASDAQ:IBB (2/13/2025, 5:20:02 PM)
After market: 137.04 0 (0%)137.04
+1.57 (+1.16%)
The current stock price of IBB is 137.04 USD. In the past month the price increased by 2.71%. In the past year, price increased by 0.97%.
The brokerage adjusted its 2025 Yorvipath sales forecast downward, expecting a more backloaded ramp.
The brokerage pointed to the company’s recent discontinuation of its NTLA-3001 program for alpha-1 antitrypsin deficiency-associated lung disease, reducing near-term growth prospects.
Biotech firms as a group declined slightly in the last year amid a tough external environment, but these three companies could grow in 2025.
Avadel Pharmaceuticals missed the fourth quarter sales estimate by 5.12%. Still, the sales of its narcolepsy drug, LUMRYZ rose by 150% YoY.
The current stock price of IBB is 137.04 USD.
The exchange symbol of ISHARES BIOTECHNOLOGY ETF is IBB and it is listed on the Nasdaq exchange.
IBB stock is listed on the Nasdaq exchange.
ChartMill assigns a technical rating of 3 / 10 to IBB. When comparing the yearly performance of all stocks, IBB turns out to be only a medium performer in the overall market: it outperformed 46.37% of all stocks.